Altıntaş, GaripKüçüker, Seref AlpHanedan, OnurDiken, Özlem ErçenDiken, Adem İlkay2026-04-012011-02Experimental and Clinical Transplantation, Cilt, 9, Sayı, 1, 2011 ss. 72-741304-0855https://hdl.handle.net/11727/14698Pneumocystis jiroveci is an important cause of mortality and morbidity among heart transplant recipients. This raises the question of prophylactic treatment for this infection. Trimethoprim-sulfamethoxazole is commonly used in P. jiroveci pneumonia prophylaxis with mild to severe adverse effects. We present the use of inhaled pentamidine as P. jiroveci prophylaxis in a patient with an allergy to trimethoprim sulfamethoxazole.enPentamidineHeart transplantationPneumocystis cariniiPneumocystis jiroveciCase Report912146-8427